{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T23:30:21Z","timestamp":1794267021633,"version":"4.9.0"},"reference-count":147,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Metab"],"DOI":"10.1038\/s42255-025-01353-3","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T09:02:44Z","timestamp":1755507764000},"page":"1732-1744","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Metabolic Messenger: growth differentiation factor 15"],"prefix":"10.1038","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9021-9879","authenticated-orcid":false,"given":"Samuel N.","family":"Breit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7817-3441","authenticated-orcid":false,"given":"Vicky W.","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,18]]},"reference":[{"key":"1353_CR1","doi-asserted-by":"publisher","first-page":"11514","DOI":"10.1073\/pnas.94.21.11514","volume":"94","author":"MR Bootcov","year":"1997","unstructured":"Bootcov, M. R. et al. MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-\u03b2 superfamily. Proc. Natl Acad. Sci. USA 94, 11514\u201311519 (1997). First identification of GDF15.","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1353_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0378-1119(97)00485-X","volume":"203","author":"LN Lawton","year":"1997","unstructured":"Lawton, L. N. et al. Identification of a novel member of the TGF-\u03b2 superfamily highly expressed in human placenta. Gene 203, 17\u201326 (1997).","journal-title":"Gene"},{"key":"1353_CR3","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S0167-4781(97)00122-X","volume":"1354","author":"R Hromas","year":"1997","unstructured":"Hromas, R. et al. PLAB, a novel placental bone morphogenetic protein. Biochim. Biophys. Acta 1354, 40\u201344 (1997).","journal-title":"Biochim. Biophys. Acta"},{"key":"1353_CR4","doi-asserted-by":"publisher","first-page":"13760","DOI":"10.1074\/jbc.273.22.13760","volume":"273","author":"VM Paralkar","year":"1998","unstructured":"Paralkar, V. M. et al. Cloning and characterization of a novel member of the transforming growth factor-\u03b2\/bone morphogenetic protein family. J. Biol. Chem. 273, 13760\u201313767 (1998).","journal-title":"J. Biol. Chem."},{"key":"1353_CR5","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0378-1119(99)00309-1","volume":"237","author":"M B\u00f6ttner","year":"1999","unstructured":"B\u00f6ttner, M. et al. Characterization of the rat, mouse, and human genes of growth\/differentiation factor-15\/macrophage inhibiting cytokine-1 (GDF-15\/MIC-1). Gene 237, 105\u2013111 (1999).","journal-title":"Gene"},{"key":"1353_CR6","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/S0026-895X(24)09260-5","volume":"59","author":"SJ Baek","year":"2001","unstructured":"Baek, S. J., Kim, K. S., Nixon, J. B., Wilson, L. C. & Eling, T. E. Cyclooxygenase inhibitors regulate the expression of a TGF-\u03b2 superfamily member that has proapoptotic and antitumorigenic activities. Mol. Pharmacol. 59, 901\u2013908 (2001).","journal-title":"Mol. Pharmacol."},{"key":"1353_CR7","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.molmed.2017.10.005","volume":"23","author":"SN Breit","year":"2017","unstructured":"Breit, S. N., Tsai, V. W. & Brown, D. A. Targeting obesity and cachexia: identification of the GFRAL receptor-MIC-1\/GDF15 pathway. Trends Mol. Med. 23, 1065\u20131067 (2017).","journal-title":"Trends Mol. Med."},{"key":"1353_CR8","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.cmet.2018.07.018","volume":"28","author":"VWW Tsai","year":"2018","unstructured":"Tsai, V. W. W., Husaini, Y., Sainsbury, A., Brown, D. A. & Breit, S. N. The MIC-1\/GDF15-GFRAL pathway in energy homeostasis: implications for obesity, cachexia, and other associated diseases. Cell Metab. 28, 353\u2013368 (2018).","journal-title":"Cell Metab."},{"key":"1353_CR9","doi-asserted-by":"publisher","first-page":"e0187349","DOI":"10.1371\/journal.pone.0187349","volume":"12","author":"OE Olsen","year":"2017","unstructured":"Olsen, O. E., Skj\u00e6rvik, A., St\u00f8rdal, B. F., Sundan, A. & Holien, T. TGF-\u03b2 contamination of purified recombinant GDF15. PLoS ONE 12, e0187349 (2017).","journal-title":"PLoS ONE"},{"key":"1353_CR10","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1038\/nm1677","volume":"13","author":"H Johnen","year":"2007","unstructured":"Johnen, H. et al. Tumor-induced anorexia and weight loss are mediated by the TGF-\u03b2 superfamily cytokine MIC-1. Nat. Med. 13, 1333\u20131340 (2007). Identified GDF15\u2019s role in triggering cancer anorexia\/cachexia.","journal-title":"Nat. Med."},{"key":"1353_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0034868","volume":"7","author":"L Macia","year":"2012","unstructured":"Macia, L. et al. Macrophage inhibitory cytokine 1 (MIC-1\/GDF15) decreases food intake, body weight and improves glucose tolerance in mice on normal & obesogenic diets. PLoS ONE 7, e34868 (2012). Transgenic GDF15 overexpressing mice displyed decreased body weight and fat mice under both normal and fat diet.","journal-title":"PLoS ONE"},{"key":"1353_CR12","doi-asserted-by":"publisher","first-page":"690","DOI":"10.18632\/aging.100687","volume":"6","author":"X Wang","year":"2014","unstructured":"Wang, X. et al. hNAG-1 increases lifespan by regulating energy metabolism and insulin\/IGF-1\/mTOR signaling. Aging 6, 690\u2013704 (2014).","journal-title":"Aging"},{"key":"1353_CR13","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1038\/ijo.2014.27","volume":"38","author":"K Chrysovergis","year":"2014","unstructured":"Chrysovergis, K. et al. NAG-1\/GDF-15 prevents obesity by increasing thermogenesis, lipolysis and oxidative metabolism. Int J. Obes. 38, 1555\u20131564 (2014).","journal-title":"Int J. Obes."},{"key":"1353_CR14","doi-asserted-by":"publisher","first-page":"e55174","DOI":"10.1371\/journal.pone.0055174","volume":"8","author":"VW Tsai","year":"2013","unstructured":"Tsai, V. W. et al. TGF-b superfamily cytokine MIC-1\/GDF15 is a physiological appetite and body weight regulator. PLoS ONE 8, e55174 (2013).","journal-title":"PLoS ONE"},{"key":"1353_CR15","doi-asserted-by":"publisher","first-page":"e100370","DOI":"10.1371\/journal.pone.0100370","volume":"9","author":"VW Tsai","year":"2014","unstructured":"Tsai, V. W. et al. The anorectic actions of the TGF\u03b2 cytokine MIC-1\/GDF15 require an intact brainstem area postrema and nucleus of the solitary tract. PLoS ONE 9, e100370 (2014). First identified the site of GDF15\u2019s action in brainstem AP and NTS.","journal-title":"PLoS ONE"},{"key":"1353_CR16","doi-asserted-by":"crossref","unstructured":"Yang, L. et al. GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand. Nat. Med. 23, 1158\u20131166 (2017). One of four studies that discovered the receptor for GDF15 located in the brainstem AP and NTS.","DOI":"10.1038\/nm.4394"},{"key":"1353_CR17","doi-asserted-by":"crossref","unstructured":"Mullican, S. E. et al. GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates. Nat. Med. 23, 1150\u20131157 (2017). One of four studies that discovered the receptor for GDF15 located in the brainstem AP and NTS.","DOI":"10.1038\/nm.4392"},{"key":"1353_CR18","unstructured":"Hsu, J. Y. et al. Non-homeostatic body weight regulation through a brainstem-restricted receptor for GDF15. Nature 550, 255\u2013259 (2017). One of four studies that discovered the receptor for GDF15 located in the brainstem AP and NTS."},{"key":"1353_CR19","doi-asserted-by":"crossref","unstructured":"Emmerson, P. J. et al. The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL. Nat. Med. 23, 1215\u20131219 (2017). One of four studies that discovered the receptor for GDF15 located in the brainstem AP and NTS.","DOI":"10.1038\/nm.4393"},{"key":"1353_CR20","doi-asserted-by":"publisher","first-page":"e00249","DOI":"10.1128\/MCB.00249-18","volume":"38","author":"JJ Li","year":"2018","unstructured":"Li, J. J. et al. Growth differentiation factor 15 maturation requires proteolytic cleavage by PCSK3, \u22125, and \u22126. Mol. Cell. Biol. 38, e00249\u201318 (2018).","journal-title":"Mol. Cell. Biol."},{"key":"1353_CR21","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1093\/emboj\/19.10.2212","volume":"19","author":"AR Bauskin","year":"2000","unstructured":"Bauskin, A. R. et al. The propeptide of macrophage inhibitory cytokine (MIC-1), a TGF-\u03b2 superfamily member, acts as a quality control determinant for correctly folded MIC-1. EMBO J. 19, 2212\u20132220 (2000).","journal-title":"EMBO J."},{"key":"1353_CR22","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1158\/0008-5472.CAN-04-3827","volume":"65","author":"AR Bauskin","year":"2005","unstructured":"Bauskin, A. R. et al. The propeptide mediates formation of stromal stores of PROMIC-1: role in determining prostate cancer outcome. Cancer Res. 65, 2330\u20132336 (2005).","journal-title":"Cancer Res."},{"key":"1353_CR23","doi-asserted-by":"publisher","first-page":"E2277","DOI":"10.1210\/jc.2014-1598","volume":"99","author":"S Li","year":"2014","unstructured":"Li, S. et al. Maturation of growth differentiation factor 15 in human placental trophoblast cells depends on the interaction with matrix metalloproteinase-26. J. Clin. Endocrinol. Metab. 99, E2277\u2013E2287 (2014).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1353_CR24","doi-asserted-by":"publisher","first-page":"20127","DOI":"10.1074\/jbc.M909580199","volume":"275","author":"PX Li","year":"2000","unstructured":"Li, P. X. et al. Placental transforming growth factor-\u03b2 is a downstream mediator of the growth arrest and apoptotic response of tumor cells to DNA damage and p53 overexpression. J. Biol. Chem. 275, 20127\u201320135 (2000).","journal-title":"J. Biol. Chem."},{"key":"1353_CR25","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1073\/pnas.97.1.109","volume":"97","author":"M Tan","year":"2000","unstructured":"Tan, M., Wang, Y., Guan, K. & Sun, Y. PTGF-\u03b2, a type \u03b2 transforming growth factor (TGF-\u03b2) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-\u03b2 signaling pathway. Proc. Natl Acad. Sci. USA 97, 109\u2013114 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1353_CR26","doi-asserted-by":"publisher","first-page":"6883","DOI":"10.1074\/jbc.M305295200","volume":"279","author":"SJ Baek","year":"2004","unstructured":"Baek, S. J., Kim, J. S., Nixon, J. B., DiAugustine, R. P. & Eling, T. E. Expression of NAG-1, a transforming growth factor-\u03b2 superfamily member, by troglitazone requires the early growth response gene EGR-1. J. Biol. Chem. 279, 6883\u20136892 (2004).","journal-title":"J. Biol. Chem."},{"key":"1353_CR27","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1093\/carcin\/bgq008","volume":"31","author":"H Yang","year":"2010","unstructured":"Yang, H., Park, S. H., Choi, H. J. & Moon, Y. The integrated stress response-associated signals modulates intestinal tumor cell growth by NSAID-activated gene 1 (NAG-1\/MIC-1\/PTGF-\u03b2). Carcinogenesis 31, 703\u2013711 (2010).","journal-title":"Carcinogenesis"},{"key":"1353_CR28","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cmet.2018.12.016","volume":"29","author":"S Patel","year":"2019","unstructured":"Patel, S. et al. GDF15 provides an endocrine signal of nutritional stress in mice and humans. Cell Metab. 29, 707\u2013718.e8 (2019).","journal-title":"Cell Metab."},{"key":"1353_CR29","doi-asserted-by":"publisher","first-page":"4212","DOI":"10.1038\/sj.onc.1205610","volume":"21","author":"M Albertoni","year":"2002","unstructured":"Albertoni, M. et al. Anoxia induces macrophage inhibitory cytokine-1 (MIC-1) in glioblastoma cells independently of p53 and HIF-1. Oncogene 21, 4212\u20134219 (2002).","journal-title":"Oncogene"},{"key":"1353_CR30","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1182\/blood-2011-03-341776","volume":"119","author":"NP Talbot","year":"2012","unstructured":"Talbot, N. P. et al. Regulation of hepcidin expression at high altitude. Blood 119, 857\u2013860 (2012).","journal-title":"Blood"},{"key":"1353_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-15-91","volume":"15","author":"SG Kalko","year":"2014","unstructured":"Kalko, S. G. et al. Transcriptomic profiling of TK2 deficient human skeletal muscle suggests a role for the p53 signalling pathway and identifies growth and differentiation factor-15 as a potential novel biomarker for mitochondrial myopathies. BMC Genomics 15, 91 (2014).","journal-title":"BMC Genomics"},{"key":"1353_CR32","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1083\/jcb.201607110","volume":"216","author":"HK Chung","year":"2017","unstructured":"Chung, H. K. et al. Growth differentiation factor 15 is a myomitokine governing systemic energy homeostasis. J. Cell Biol. 216, 149\u2013165 (2017).","journal-title":"J. Cell Biol."},{"key":"1353_CR33","doi-asserted-by":"publisher","first-page":"280","DOI":"10.2337\/dc16-1682","volume":"40","author":"HC Gerstein","year":"2017","unstructured":"Gerstein, H. C. et al. Growth differentiation factor 15 as a novel biomarker for metformin. Diabetes Care 40, 280\u2013283 (2017).","journal-title":"Diabetes Care"},{"key":"1353_CR34","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1080\/13547500903062976","volume":"14","author":"I Tchou","year":"2009","unstructured":"Tchou, I. et al. Growth-differentiation factor-15, endoglin and N-terminal pro-brain natriuretic peptide induction in athletes participating in an ultramarathon foot race. Biomarkers 14, 418\u2013422 (2009).","journal-title":"Biomarkers"},{"key":"1353_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.550102","volume":"11","author":"L Campderr\u00f3s","year":"2020","unstructured":"Campderr\u00f3s, L. et al. Altered GDF15 and FGF21 levels in response to strenuous exercise: a study in marathon runners. Front. Physiol. 11, 550102 (2020).","journal-title":"Front. Physiol."},{"key":"1353_CR36","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1161\/01.RES.0000202805.73038.48","volume":"98","author":"T Kempf","year":"2006","unstructured":"Kempf, T. et al. The transforming growth factor-\u03b2 superfamily member growth-differentiation factor-15 protects the heart from ischemia\/reperfusion injury. Circ. Res. 98, 351\u2013360 (2006).","journal-title":"Circ. Res."},{"key":"1353_CR37","doi-asserted-by":"crossref","unstructured":"Brown, D. A. et al. Antibody-based approach to high-volume genotyping for MIC-1 polymorphism. Biotechniques 33, 118\u2013120 (2002).","DOI":"10.2144\/02331rr03"},{"key":"1353_CR38","first-page":"2642","volume":"9","author":"DA Brown","year":"2003","unstructured":"Brown, D. A. et al. MIC-1 serum level and genotype: associations with progress and prognosis of colorectal carcinoma. Clin. Cancer Res. 9, 2642\u20132650 (2003).","journal-title":"Clin. Cancer Res."},{"key":"1353_CR39","doi-asserted-by":"publisher","first-page":"e0133362","DOI":"10.1371\/journal.pone.0133362","volume":"10","author":"VW Tsai","year":"2015","unstructured":"Tsai, V. W. et al. Serum levels of human MIC-1\/GDF15 vary in a diurnal pattern, do not display a profile suggestive of a satiety factor and are related to BMI. PLoS ONE 10, e0133362 (2015).","journal-title":"PLoS ONE"},{"key":"1353_CR40","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1016\/S0140-6736(02)09093-1","volume":"359","author":"DA Brown","year":"2002","unstructured":"Brown, D. A. et al. Concentration in plasma of macrophage inhibitory cytokine-1 and risk of cardiovascular events in women: a nested case-control study. Lancet 359, 2159\u20132163 (2002).","journal-title":"Lancet"},{"key":"1353_CR41","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1111\/j.1474-9726.2010.00629.x","volume":"9","author":"FE Wiklund","year":"2010","unstructured":"Wiklund, F. E. et al. Macrophage inhibitory cytokine-1 (MIC-1\/GDF15): a new marker of all-cause mortality. Aging Cell 9, 1057\u20131064 (2010). GDF15 identified as blood marker for all-cause mortality.","journal-title":"Aging Cell"},{"key":"1353_CR42","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1210\/en.2008-0952","volume":"150","author":"Q Ding","year":"2009","unstructured":"Ding, Q. et al. Identification of macrophage inhibitory cytokine-1 in adipose tissue and its secretion as an adipokine by human adipocytes. Endocrinology 150, 1688\u20131696 (2009).","journal-title":"Endocrinology"},{"key":"1353_CR43","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1038\/s42255-019-0146-4","volume":"1","author":"EA Day","year":"2019","unstructured":"Day, E. A. et al. Metformin-induced increases in GDF15 are important for suppressing appetite and promoting weight loss. Nat. Metab. 1, 1202\u20131208 (2019). GDF15 is required for metformin-induced body weight loss.","journal-title":"Nat. Metab."},{"key":"1353_CR44","first-page":"1023","volume":"2","author":"H Yang","year":"2003","unstructured":"Yang, H., Filipovic, Z., Brown, D., Breit, S. N. & Vassilev, L. T. Macrophage inhibitory cytokine-1: a novel biomarker for p53 pathway activation. Mol. Cancer Ther. 2, 1023\u20131029 (2003).","journal-title":"Mol. Cancer Ther."},{"key":"1353_CR45","doi-asserted-by":"publisher","first-page":"e0115372","DOI":"10.1371\/journal.pone.0115372","volume":"10","author":"R Altena","year":"2015","unstructured":"Altena, R. et al. Growth differentiation factor 15 (GDF-15) plasma levels increase during bleomycin- and cisplatin-based treatment of testicular cancer patients and relate to endothelial damage. PLoS ONE 10, e0115372 (2015).","journal-title":"PLoS ONE"},{"key":"1353_CR46","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1667\/RR3492.1","volume":"165","author":"R Okazaki","year":"2006","unstructured":"Okazaki, R., Moon, Y., Norimura, T. & Eling, T. Ionizing radiation enhances the expression of the nonsteroidal anti-inflammatory drug-activated gene (NAG1) by increasing the expression of TP53 in human colon cancer cells. Radiat. Res. 165, 125\u2013130 (2006).","journal-title":"Radiat. Res."},{"key":"1353_CR47","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1016\/j.ijrobp.2006.08.004","volume":"66","author":"E Kis","year":"2006","unstructured":"Kis, E. et al. Microarray analysis of radiation response genes in primary human fibroblasts. Int. J. Radiat. Oncol. Biol. Phys. 66, 1506\u20131514 (2006).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1353_CR48","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1158\/1078-0432.CCR-03-0165","volume":"10","author":"J Koopmann","year":"2004","unstructured":"Koopmann, J. et al. Serum macrophage inhibitory cytokine 1 as a marker of pancreatic and other periampullary cancers. Clin. Cancer Res. 10, 2386\u20132392 (2004).","journal-title":"Clin. Cancer Res."},{"key":"1353_CR49","doi-asserted-by":"publisher","first-page":"6658","DOI":"10.1158\/1078-0432.CCR-08-3126","volume":"15","author":"DA Brown","year":"2009","unstructured":"Brown, D. A. et al. Macrophage inhibitory cytokine 1: a new prognostic marker in prostate cancer. Clin. Cancer Res. 15, 6658\u20136664 (2009).","journal-title":"Clin. Cancer Res."},{"key":"1353_CR50","doi-asserted-by":"publisher","first-page":"3410","DOI":"10.1073\/pnas.0530278100","volume":"100","author":"JB Welsh","year":"2003","unstructured":"Welsh, J. B. et al. Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum. Proc. Natl Acad. Sci. USA 100, 3410\u20133415 (2003). GDF15 overexpressed in cancer tissues and blood.","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1353_CR51","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.2337\/dc09-2174","volume":"33","author":"M Lajer","year":"2010","unstructured":"Lajer, M., Jorsal, A., Tarnow, L., Parving, H. H. & Rossing, P. Plasma growth differentiation factor-15 independently predicts all-cause and cardiovascular mortality as well as deterioration of kidney function in type 1 diabetic patients with nephropathy. Diabetes Care 33, 1567\u20131572 (2010).","journal-title":"Diabetes Care"},{"key":"1353_CR52","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1373\/clinchem.2013.205716","volume":"59","author":"JE Ho","year":"2013","unstructured":"Ho, J. E. et al. Biomarkers of cardiovascular stress and incident chronic kidney disease. Clin. Chem. 59, 1613\u20131620 (2013).","journal-title":"Clin. Chem."},{"key":"1353_CR53","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1373\/clinchem.2006.076828","volume":"53","author":"T Kempf","year":"2007","unstructured":"Kempf, T. et al. Circulating concentrations of growth-differentiation factor 15 in apparently healthy elderly individuals and patients with chronic heart failure as assessed by a new immunoradiometric sandwich assay. Clin. Chem. 53, 284\u2013291 (2007).","journal-title":"Clin. Chem."},{"key":"1353_CR54","doi-asserted-by":"publisher","first-page":"e0127518","DOI":"10.1371\/journal.pone.0127518","volume":"10","author":"X Liu","year":"2015","unstructured":"Liu, X. et al. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma. PLoS ONE 10, e0127518 (2015).","journal-title":"PLoS ONE"},{"key":"1353_CR55","doi-asserted-by":"publisher","first-page":"e0148709","DOI":"10.1371\/journal.pone.0148709","volume":"11","author":"R Montero","year":"2016","unstructured":"Montero, R. et al. GDF-15 is elevated in children with mitochondrial diseases and is induced by mitochondrial dysfunction. PLoS ONE 11, e0148709 (2016).","journal-title":"PLoS ONE"},{"key":"1353_CR56","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1002\/ana.24506","volume":"78","author":"S Yatsuga","year":"2015","unstructured":"Yatsuga, S. et al. Growth differentiation factor 15 as a useful biomarker for mitochondrial disorders. Ann. Neurol. 78, 814\u2013823 (2015).","journal-title":"Ann. Neurol."},{"key":"1353_CR57","first-page":"4781","volume":"85","author":"AG Moore","year":"2000","unstructured":"Moore, A. G. et al. The transforming growth factor-ss superfamily cytokine macrophage inhibitory cytokine-1 is present in high concentrations in the serum of pregnant women. J. Clin. Endocrinol. Metab. 85, 4781\u20134788 (2000).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1353_CR58","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0140-6736(03)15265-8","volume":"363","author":"S Tong","year":"2004","unstructured":"Tong, S. et al. Serum concentrations of macrophage inhibitory cytokine 1 (MIC 1) as a predictor of miscarriage. Lancet 363, 129\u2013130 (2004).","journal-title":"Lancet"},{"key":"1353_CR59","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1161\/CIRCULATIONAHA.110.979740","volume":"123","author":"LB Daniels","year":"2011","unstructured":"Daniels, L. B., Clopton, P., Laughlin, G. A., Maisel, A. S. & Barrett-Connor, E. Growth-differentiation factor-15 is a robust, independent predictor of 11-year mortality risk in community-dwelling older adults: the Rancho Bernardo Study. Circulation 123, 2101\u20132110 (2011).","journal-title":"Circulation"},{"key":"1353_CR60","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1373\/clinchem.2012.201210","volume":"59","author":"KM Eggers","year":"2013","unstructured":"Eggers, K. M., Kempf, T., Wallentin, L., Wollert, K. C. & Lind, L. Change in growth differentiation factor 15 concentrations over time independently predicts mortality in community-dwelling elderly individuals. Clin. Chem. 59, 1091\u20131098 (2013).","journal-title":"Clin. Chem."},{"key":"1353_CR61","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1093\/jalm\/jfac055","volume":"7","author":"Y Karusheva","year":"2022","unstructured":"Karusheva, Y. et al. The common H202D variant in GDF-15 does not affect its bioactivity but can significantly interfere with measurement of its circulating levels. J. Appl. Lab. Med. 7, 1388\u20131400 (2022).","journal-title":"J. Appl. Lab. Med."},{"key":"1353_CR62","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1146\/annurev-physiol-022020-045449","volume":"83","author":"SN Breit","year":"2021","unstructured":"Breit, S. N., Brown, D. A. & Tsai, V. W. The GDF15\u2013GFRAL pathway in health and metabolic disease: friend or foe. Annu. Rev. Physiol. 83, 127\u2013151 (2021).","journal-title":"Annu. Rev. Physiol."},{"key":"1353_CR63","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1471-4159.2005.03372.x","volume":"95","author":"Z Li","year":"2005","unstructured":"Li, Z. et al. Identification, expression and functional characterization of the GRAL gene. J. Neurochem. 95, 361\u2013376 (2005).","journal-title":"J. Neurochem."},{"key":"1353_CR64","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.2337\/db22-0019","volume":"72","author":"H Zhang","year":"2023","unstructured":"Zhang, H. et al. GDF15 mediates the effect of skeletal muscle contraction on glucose-stimulated insulin secretion. Diabetes 72, 1070\u20131082 (2023).","journal-title":"Diabetes"},{"key":"1353_CR65","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13046-018-0744-0","volume":"37","author":"S Li","year":"2018","unstructured":"Li, S., Ma, Y. M., Zheng, P. S. & Zhang, P. GDF15 promotes the proliferation of cervical cancer cells by phosphorylating AKT1 and Erk1\/2 through the receptor ErbB2. J. Exp. Clin. Cancer Res. 37, 80 (2018).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"1353_CR66","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1093\/carcin\/bgn031","volume":"29","author":"KK Kim","year":"2008","unstructured":"Kim, K. K., Lee, J. J., Yang, Y., You, K. H. & Lee, J. H. Macrophage inhibitory cytokine-1 activates AKT and ERK-1\/2 via the transactivation of ErbB2 in human breast and gastric cancer cells. Carcinogenesis 29, 704\u2013712 (2008).","journal-title":"Carcinogenesis"},{"key":"1353_CR67","doi-asserted-by":"publisher","first-page":"e002787","DOI":"10.1136\/jitc-2021-002787","volume":"9","author":"Z Wang","year":"2021","unstructured":"Wang, Z. et al. GDF15 induces immunosuppression via CD48 on regulatory T cells in hepatocellular carcinoma. J. Immunother. Cancer 9, e002787 (2021).","journal-title":"J. Immunother. Cancer"},{"key":"1353_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2021.112522","volume":"402","author":"Y Gao","year":"2021","unstructured":"Gao, Y. et al. Growth differentiation factor-15 promotes immune escape of ovarian cancer via targeting CD44 in dendritic cells. Exp. Cell. Res. 402, 112522 (2021).","journal-title":"Exp. Cell. Res."},{"key":"1353_CR69","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20210420","volume":"219","author":"A Patsalos","year":"2022","unstructured":"Patsalos, A. et al. A growth factor-expressing macrophage subpopulation orchestrates regenerative inflammation via GDF-15. J. Exp. Med. 219, e20210420 (2022).","journal-title":"J. Exp. Med."},{"key":"1353_CR70","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.cmet.2023.06.016","volume":"35","author":"KA Sj\u00f8berg","year":"2023","unstructured":"Sj\u00f8berg, K. A. et al. GDF15 increases insulin action in the liver and adipose tissue via a \u03b2-adrenergic receptor-mediated mechanism. Cell Metab. 35, 1327\u20131340.e5 (2023).","journal-title":"Cell Metab."},{"key":"1353_CR71","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/s42255-021-00366-y","volume":"3","author":"JH Weng","year":"2021","unstructured":"Weng, J. H. et al. Colchicine acts selectively in the liver to induce hepatokines that inhibit myeloid cell activation. Nat. Metab. 3, 513\u2013522 (2021).","journal-title":"Nat. Metab."},{"key":"1353_CR72","doi-asserted-by":"publisher","first-page":"123","DOI":"10.12688\/wellcomeopenres.14818.1","volume":"3","author":"CJ Petry","year":"2018","unstructured":"Petry, C. J. et al. Associations of vomiting and antiemetic use in pregnancy with levels of circulating GDF15 early in the second trimester: a nested case-control study. Wellcome Open Res 3, 123 (2018). GDF15 associated with pregnancy vomiting and nausea.","journal-title":"Wellcome Open Res"},{"key":"1353_CR73","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/s41586-023-06921-9","volume":"625","author":"M Fejzo","year":"2024","unstructured":"Fejzo, M. et al. GDF15 linked to maternal risk of nausea and vomiting during pregnancy. Nature 625, 760\u2013767 (2024).","journal-title":"Nature"},{"key":"1353_CR74","doi-asserted-by":"publisher","first-page":"107543","DOI":"10.1016\/j.celrep.2020.107543","volume":"31","author":"T Borner","year":"2020","unstructured":"Borner, T. et al. GDF15 induces an aversive visceral malaise state that drives anorexia and weight loss. Cell Rep. 31, 107543 (2020).","journal-title":"Cell Rep."},{"key":"1353_CR75","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.neuron.2020.11.010","volume":"109","author":"C Zhang","year":"2021","unstructured":"Zhang, C. et al. Area postrema cell types that mediate nausea-associated behaviors. Neuron 109, 461\u2013472.e5 (2021).","journal-title":"Neuron"},{"key":"1353_CR76","doi-asserted-by":"publisher","first-page":"e55164","DOI":"10.7554\/eLife.55164","volume":"9","author":"AA Worth","year":"2020","unstructured":"Worth, A. A. et al. The cytokine GDF15 signals through a population of brainstem cholecystokinin neurons to mediate anorectic signalling. eLife 9, e55164 (2020).","journal-title":"eLife"},{"key":"1353_CR77","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/nn.4574","volume":"20","author":"CA Campos","year":"2017","unstructured":"Campos, C. A. et al. Cancer-induced anorexia and malaise are mediated by CGRP neurons in the parabrachial nucleus. Nat. Neurosci. 20, 934\u2013942 (2017).","journal-title":"Nat. Neurosci."},{"key":"1353_CR78","doi-asserted-by":"publisher","first-page":"4582","DOI":"10.1523\/JNEUROSCI.3729-14.2015","volume":"35","author":"ME Carter","year":"2015","unstructured":"Carter, M. E., Han, S. & Palmiter, R. D. Parabrachial calcitonin gene-related peptide neurons mediate conditioned taste aversion. J. Neurosci. 35, 4582\u20134586 (2015).","journal-title":"J. Neurosci."},{"key":"1353_CR79","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2021357118","volume":"118","author":"PV Sabatini","year":"2021","unstructured":"Sabatini, P. V. et al. GFRAL-expressing neurons suppress food intake via aversive pathways. Proc. Natl Acad. Sci. USA 118, e2021357118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1353_CR80","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.cmet.2019.12.004","volume":"31","author":"T Borner","year":"2020","unstructured":"Borner, T. et al. GDF15 induces anorexia through nausea and emesis. Cell Metab. 31, 351\u2013362.e5 (2020).","journal-title":"Cell Metab."},{"key":"1353_CR81","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1055\/a-0661-0287","volume":"78","author":"MS Fejzo","year":"2018","unstructured":"Fejzo, M. S., Arzy, D., Tian, R., MacGibbon, K. W. & Mullin, P. M. Evidence GDF15 plays a role in familial and recurrent hyperemesis gravidarum. Geburtshilfe Frauenheilkd. 78, 866\u2013870 (2018).","journal-title":"Geburtshilfe Frauenheilkd."},{"key":"1353_CR82","doi-asserted-by":"publisher","first-page":"e14886","DOI":"10.1111\/nmo.14886","volume":"37","author":"T Borner","year":"2024","unstructured":"Borner, T., Pataro, A. M. & De Jonghe, B. C. Central mechanisms of emesis: a role for GDF15. Neurogastroenterol. Motil. 37, e14886 (2024).","journal-title":"Neurogastroenterol. Motil."},{"key":"1353_CR83","doi-asserted-by":"publisher","first-page":"bnaa007","DOI":"10.1210\/endrev\/bnaa007","volume":"41","author":"SM Lockhart","year":"2020","unstructured":"Lockhart, S. M., Saudek, V. & O\u2019Rahilly, S. GDF15: a hormone conveying somatic distress to the brain. Endocr. Rev. 41, bnaa007 (2020).","journal-title":"Endocr. Rev."},{"key":"1353_CR84","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cmet.2022.12.011","volume":"35","author":"O Benichou","year":"2023","unstructured":"Benichou, O. et al. Discovery, development, and clinical proof of mechanism of LY3463251, a long-acting GDF15 receptor agonist. Cell Metab. 35, 274\u2013286.e10 (2023). First clinical trial of GDF15 analogue showed modest effect in decreasing body weight.","journal-title":"Cell Metab."},{"key":"1353_CR85","doi-asserted-by":"publisher","first-page":"13640","DOI":"10.1523\/JNEUROSCI.1133-09.2009","volume":"29","author":"J Strelau","year":"2009","unstructured":"Strelau, J. et al. Progressive postnatal motoneuron loss in mice lacking GDF-15. J. Neurosci. 29, 13640\u201313648 (2009).","journal-title":"J. Neurosci."},{"key":"1353_CR86","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1053\/j.gastro.2006.09.015","volume":"131","author":"SJ Baek","year":"2006","unstructured":"Baek, S. J. et al. Nonsteroidal anti-inflammatory drug-activated gene-1 over expression in transgenic mice suppresses intestinal neoplasia. Gastroenterology 131, 1553\u20131560 (2006).","journal-title":"Gastroenterology"},{"key":"1353_CR87","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1038\/s41366-019-0365-5","volume":"43","author":"VW Tsai","year":"2019","unstructured":"Tsai, V. W. et al. GDF15 mediates adiposity resistance through actions on GFRAL neurons in the hindbrain AP\/NTS. Int J. Obes. 43, 2370\u20132380 (2019).","journal-title":"Int J. Obes."},{"key":"1353_CR88","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41586-023-06249-4","volume":"619","author":"D Wang","year":"2023","unstructured":"Wang, D. et al. GDF15 promotes weight loss by enhancing energy expenditure in muscle. Nature 619, 143\u2013150 (2023).","journal-title":"Nature"},{"key":"1353_CR89","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1038\/s42255-024-01135-3","volume":"6","author":"AM Gurtan","year":"2024","unstructured":"Gurtan, A. M. et al. Identification and characterization of human GDF15 knockouts. Nat. Metab. 6, 1913\u20131921 (2024).","journal-title":"Nat. Metab."},{"key":"1353_CR90","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1038\/s42255-024-01136-2","volume":"6","author":"SN Breit","year":"2024","unstructured":"Breit, S. N. & O\u2019Rahilly, S. Humans without GDF15 reassure drug developers. Nat. Metab. 6, 1850\u20131851 (2024).","journal-title":"Nat. Metab."},{"key":"1353_CR91","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ebiom.2019.02.021","volume":"41","author":"CL Cheung","year":"2019","unstructured":"Cheung, C. L., Tan, K. C. B., Au, P. C. M., Li, G. H. Y. & Cheung, B. M. Y. Evaluation of GDF15 as a therapeutic target of cardiometabolic diseases in human: A Mendelian randomization study. EBioMedicine 41, 85\u201390 (2019).","journal-title":"EBioMedicine"},{"key":"1353_CR92","doi-asserted-by":"crossref","unstructured":"Fejzo, M. et al. Multi-ancestry GWAS of severe pregnancy nausea and vomiting identifies risk loci associated with appetite, insulin signaling, and brain plasticity. Res. Sq. 3, 5487737 (2024).","DOI":"10.1101\/2024.11.19.24317559"},{"key":"1353_CR93","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/s41574-021-00529-7","volume":"17","author":"D Wang","year":"2021","unstructured":"Wang, D. et al. GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease. Nat. Rev. Endocrinol. 17, 592\u2013607 (2021).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1353_CR94","doi-asserted-by":"crossref","unstructured":"Groarke, J. D. et al. Ponsegromab for the treatment of cancer cachexia. N. Engl. J. Med. 391, 2291\u20132303 (2024). GDF15 antibody mitigated anorexia\u2013cachexia in advance cancer in phase II trial.","DOI":"10.1056\/NEJMoa2409515"},{"key":"1353_CR95","doi-asserted-by":"publisher","first-page":"e12845","DOI":"10.1111\/ijpo.12845","volume":"17","author":"G Carreras-Badosa","year":"2022","unstructured":"Carreras-Badosa, G. et al. A 24-month metformin treatment study of children with obesity: changes in circulating GDF-15 and associations with changes in body weight and visceral fat. Pediatr. Obes. 17, e12845 (2022).","journal-title":"Pediatr. Obes."},{"key":"1353_CR96","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.cmet.2023.06.009","volume":"35","author":"SN Breit","year":"2023","unstructured":"Breit, S. N. et al. GDF15 enhances body weight and adiposity reduction in obese mice by leveraging the leptin pathway. Cell Metab. 35, 1341\u20131355.e3 (2023).","journal-title":"Cell Metab."},{"key":"1353_CR97","doi-asserted-by":"publisher","first-page":"E10","DOI":"10.1152\/ajpendo.00468.2002","volume":"285","author":"WA Banks","year":"2003","unstructured":"Banks, W. A. & Farrell, C. L. Impaired transport of leptin across the blood-brain barrier in obesity is acquired and reversible. Am. J. Physiol. Endocrinol. Metab. 285, E10\u2013E15 (2003).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"1353_CR98","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/nm0596-589","volume":"2","author":"MW Schwartz","year":"1996","unstructured":"Schwartz, M. W., Peskind, E., Raskind, M., Boyko, E. J. & Porte, D. Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans. Nat. Med. 2, 589\u2013593 (1996).","journal-title":"Nat. Med."},{"key":"1353_CR99","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-024-03104-9","volume":"21","author":"Z Feng","year":"2024","unstructured":"Feng, Z., Fang, C., Ma, Y. & Chang, J. Obesity-induced blood\u2013brain barrier dysfunction: phenotypes and mechanisms. J. Neuroinflammation 21, 110 (2024).","journal-title":"J. Neuroinflammation"},{"key":"1353_CR100","doi-asserted-by":"crossref","unstructured":"Deng, Y. T. et al. Atlas of the plasma proteome in health and disease in 53,026 adults. Cell 188, 253\u2013271 (2024).","DOI":"10.1016\/j.cell.2024.10.045"},{"key":"1353_CR101","doi-asserted-by":"crossref","unstructured":"Townsend, L. K. et al. GDF15 links adipose tissue lipolysis with anxiety. Nat. Metab. 7, 1004\u20131017 (2025).","DOI":"10.1038\/s42255-025-01264-3"},{"key":"1353_CR102","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2024.156126","volume":"164","author":"YL Chen","year":"2024","unstructured":"Chen, Y. L. et al. Identifying proteins and pathways associated with multimorbidity in 53,026 adults. Metabolism 164, 156126 (2024).","journal-title":"Metabolism"},{"key":"1353_CR103","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1530\/EJE-12-0466","volume":"167","author":"T Kempf","year":"2012","unstructured":"Kempf, T. et al. Growth differentiation factor 15 predicts future insulin resistance and impaired glucose control in obese nondiabetic individuals: results from the XENDOS trial. Eur. J. Endocrinol. 167, 671\u2013678 (2012).","journal-title":"Eur. J. Endocrinol."},{"key":"1353_CR104","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1373\/clinchem.2010.153726","volume":"57","author":"G Vila","year":"2011","unstructured":"Vila, G. et al. The relationship between insulin resistance and the cardiovascular biomarker growth differentiation factor-15 in obese patients. Clin. Chem. 57, 309\u2013316 (2011).","journal-title":"Clin. Chem."},{"key":"1353_CR105","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1530\/EJE-09-0417","volume":"161","author":"I Dost\u00e1lov\u00e1","year":"2009","unstructured":"Dost\u00e1lov\u00e1, I. et al. Increased serum concentrations of macrophage inhibitory cytokine-1 in patients with obesity and type 2 diabetes mellitus: the influence of very low calorie diet. Eur. J. Endocrinol. 161, 397\u2013404 (2009).","journal-title":"Eur. J. Endocrinol."},{"key":"1353_CR106","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1159\/000338729","volume":"5","author":"K Schindler","year":"2012","unstructured":"Schindler, K. et al. The impact of type 2 diabetes on circulating adipokines in patients with metabolic syndrome. Obes. Facts 5, 270\u2013276 (2012).","journal-title":"Obes. Facts"},{"key":"1353_CR107","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.3346\/jkms.2016.31.9.1413","volume":"31","author":"MY Shin","year":"2016","unstructured":"Shin, M. Y. et al. Association between growth differentiation factor 15 (GDF15) and cardiovascular risk in patients with newly diagnosed type 2 diabetes mellitus. J. Korean Med. Sci. 31, 1413\u20131418 (2016).","journal-title":"J. Korean Med. Sci."},{"key":"1353_CR108","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s00125-018-4751-7","volume":"62","author":"X Bao","year":"2019","unstructured":"Bao, X. et al. Growth differentiation factor 15 is positively associated with incidence of diabetes mellitus: the Malm\u00f6 diet and cancer-cardiovascular cohort. Diabetologia 62, 78\u201386 (2019).","journal-title":"Diabetologia"},{"key":"1353_CR109","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1159\/000448076","volume":"86","author":"L Bozkurt","year":"2016","unstructured":"Bozkurt, L. et al. The cross-link between adipokines, insulin resistance and obesity in offspring of diabetic pregnancies. Horm. Res. Paediatr. 86, 300\u2013308 (2016).","journal-title":"Horm. Res. Paediatr."},{"key":"1353_CR110","doi-asserted-by":"publisher","first-page":"472","DOI":"10.4093\/dmj.2014.38.6.472","volume":"38","author":"JH Hong","year":"2014","unstructured":"Hong, J. H. et al. GDF15 is a novel biomarker for impaired fasting glucose. Diabetes Metab. J. 38, 472\u2013479 (2014).","journal-title":"Diabetes Metab. J."},{"key":"1353_CR111","doi-asserted-by":"publisher","first-page":"1240843","DOI":"10.1155\/2016\/1240843","volume":"2016","author":"MM Yalcin","year":"2016","unstructured":"Yalcin, M. M. et al. GDF-15 and hepcidin levels in nonanemic patients with impaired glucose tolerance. J. Diabetes Res. 2016, 1240843 (2016).","journal-title":"J. Diabetes Res."},{"key":"1353_CR112","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/s41586-019-1911-y","volume":"578","author":"AP Coll","year":"2020","unstructured":"Coll, A. P. et al. GDF15 mediates the effects of metformin on body weight and energy balance. Nature 578, 444\u2013448 (2020).","journal-title":"Nature"},{"key":"1353_CR113","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-51866-2","volume":"14","author":"JWR Kincaid","year":"2024","unstructured":"Kincaid, J. W. R. et al. The gastrointestinal tract is a major source of the acute metformin-stimulated rise in GDF15. Sci. Rep. 14, 1899 (2024).","journal-title":"Sci. Rep."},{"key":"1353_CR114","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.cmet.2023.03.014","volume":"35","author":"SY Zhang","year":"2023","unstructured":"Zhang, S. Y. et al. Metformin triggers a kidney GDF15-dependent area postrema axis to regulate food intake and body weight. Cell Metab. 35, 875\u2013886.e5 (2023).","journal-title":"Cell Metab."},{"key":"1353_CR115","doi-asserted-by":"publisher","first-page":"426","DOI":"10.2337\/db23-0705","volume":"73","author":"SY Zhang","year":"2024","unstructured":"Zhang, S. Y., Danaei, Z., Bruce, K., Chiu, J. F. M. & Lam, T. K. T. Acute activation of GFRAL in the area postrema contributes to glucose regulation independent of weight. Diabetes 73, 426\u2013433 (2024).","journal-title":"Diabetes"},{"key":"1353_CR116","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/ijo.2017.258","volume":"42","author":"VW Tsai","year":"2018","unstructured":"Tsai, V. W. et al. Treatment with the TGF-\u03b2 superfamily cytokine MIC-1\/GDF15 reduces the adiposity and corrects the metabolic dysfunction of mice with diet-induced obesity. Int J. Obes. 42, 561\u2013571 (2018).","journal-title":"Int J. Obes."},{"key":"1353_CR117","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.molmet.2017.12.016","volume":"9","author":"M Kleinert","year":"2018","unstructured":"Kleinert, M. et al. Exercise increases circulating GDF15 in humans. Mol. Metab. 9, 187\u2013191 (2018).","journal-title":"Mol. Metab."},{"key":"1353_CR118","doi-asserted-by":"publisher","first-page":"E829","DOI":"10.1152\/ajpendo.00439.2018","volume":"316","author":"H Zhang","year":"2019","unstructured":"Zhang, H., Fealy, C. E. & Kirwan, J. P. Exercise training promotes a GDF15-associated reduction in fat mass in older adults with obesity. Am. J. Physiol. Endocrinol. Metab. 316, E829\u2013E836 (2019).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"1353_CR119","doi-asserted-by":"publisher","DOI":"10.1016\/j.appet.2022.106423","volume":"182","author":"JS Quist","year":"2023","unstructured":"Quist, J. S. et al. Effects of acute exercise and exercise training on plasma GDF15 concentrations and associations with appetite and cardiometabolic health in individuals with overweight or obesity: a secondary analysis of a randomized controlled trial. Appetite 182, 106423 (2023).","journal-title":"Appetite"},{"key":"1353_CR120","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21309-x","volume":"12","author":"AB Klein","year":"2021","unstructured":"Klein, A. B. et al. Pharmacological but not physiological GDF15 suppresses feeding and the motivation to exercise. Nat. Commun. 12, 1041 (2021).","journal-title":"Nat. Commun."},{"key":"1353_CR121","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1037948","volume":"13","author":"P Plomgaard","year":"2022","unstructured":"Plomgaard, P. et al. GDF15 is an exercise-induced hepatokine regulated by glucagon and insulin in humans. Front Endocrinol. 13, 1037948 (2022).","journal-title":"Front Endocrinol."},{"key":"1353_CR122","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-56922-w","volume":"9","author":"CI Gil","year":"2019","unstructured":"Gil, C. I. et al. Role of GDF15 in active lifestyle induced metabolic adaptations and acute exercise response in mice. Sci. Rep. 9, 20120 (2019).","journal-title":"Sci. Rep."},{"key":"1353_CR123","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2106868118","volume":"118","author":"I Cimino","year":"2021","unstructured":"Cimino, I. et al. Activation of the hypothalamic-pituitary-adrenal axis by exogenous and endogenous GDF15. Proc. Natl Acad. Sci. USA 118, e2106868118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1353_CR124","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.131870","volume":"5","author":"C Laurens","year":"2020","unstructured":"Laurens, C. et al. Growth and differentiation factor 15 is secreted by skeletal muscle during exercise and promotes lipolysis in humans. JCI Insight 5, e131870 (2020).","journal-title":"JCI Insight"},{"key":"1353_CR125","doi-asserted-by":"crossref","unstructured":"Arbeau, M. et al. GDF15 associates with, but is not responsible for, exercise-induced increases in corticosterone and indices of lipid utilization in mice. J. Appl. Physiol. 137, 1512\u20131523 (2024).","DOI":"10.1152\/japplphysiol.00519.2024"},{"key":"1353_CR126","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/jlb.65.1.2","volume":"65","author":"WD Fairlie","year":"1999","unstructured":"Fairlie, W. D. et al. MIC-1 is a novel TGF-\u03b2 superfamily cytokine associated with macrophage activation. J. Leukoc. Biol. 65, 2\u20135 (1999).","journal-title":"J. Leukoc. Biol."},{"key":"1353_CR127","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1053\/plac.2002.0881","volume":"24","author":"AB Marjono","year":"2003","unstructured":"Marjono, A. B. et al. Macrophage inhibitory cytokine-1 in gestational tissues and maternal serum in normal and pre-eclamptic pregnancy. Placenta 24, 100\u2013106 (2003).","journal-title":"Placenta"},{"key":"1353_CR128","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03258-0","volume":"9","author":"MS Fejzo","year":"2018","unstructured":"Fejzo, M. S. et al. Placenta and appetite genes GDF15 and IGFBP7 are associated with hyperemesis gravidarum. Nat. Commun. 9, 1178 (2018). GDF15 linked to hyperemesis gravidarum.","journal-title":"Nat. Commun."},{"key":"1353_CR129","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1111\/1471-0528.17129","volume":"129","author":"MS Fejzo","year":"2022","unstructured":"Fejzo, M. S., MacGibbon, K. W., First, O., Quan, C. & Mullin, P. M. Whole-exome sequencing uncovers new variants in GDF15 associated with hyperemesis gravidarum. BJOG 129, 1845\u20131852 (2022).","journal-title":"BJOG"},{"key":"1353_CR130","doi-asserted-by":"publisher","first-page":"e72437","DOI":"10.1371\/journal.pone.0072437","volume":"8","author":"TJ Kaitu\u2019u-Lino","year":"2013","unstructured":"Kaitu\u2019u-Lino, T. J. et al. Plasma MIC-1 and PAPP-a levels are decreased among women presenting to an early pregnancy assessment unit, have fetal viability confirmed but later miscarry. PLoS ONE 8, e72437 (2013).","journal-title":"PLoS ONE"},{"key":"1353_CR131","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13514","volume":"56","author":"C Lyu","year":"2023","unstructured":"Lyu, C. et al. Insufficient GDF15 expression predisposes women to unexplained recurrent pregnancy loss by impairing extravillous trophoblast invasion. Cell Prolif. 56, e13514 (2023).","journal-title":"Cell Prolif."},{"key":"1353_CR132","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39817-3","volume":"14","author":"M Haake","year":"2023","unstructured":"Haake, M. et al. Tumor-derived GDF-15 blocks LFA-1 dependent T cell recruitment and suppresses responses to anti-PD-1 treatment. Nat. Commun. 14, 4253 (2023).","journal-title":"Nat. Commun."},{"key":"1353_CR133","doi-asserted-by":"publisher","first-page":"e78618","DOI":"10.1371\/journal.pone.0078618","volume":"8","author":"Z Zhou","year":"2013","unstructured":"Zhou, Z. et al. Growth differentiation factor-15 suppresses maturation and function of dendritic cells and inhibits tumor-specific immune response. PLoS ONE 8, e78618 (2013).","journal-title":"PLoS ONE"},{"key":"1353_CR134","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/s41390-019-0633-z","volume":"87","author":"M D\u00edaz","year":"2020","unstructured":"D\u00edaz, M. et al. Circulating growth-and-differentiation factor-15 in early life: relation to prenatal and postnatal growth and adiposity measurements. Pediatr. Res. 87, 897\u2013902 (2020).","journal-title":"Pediatr. Res."},{"key":"1353_CR135","doi-asserted-by":"publisher","first-page":"E303","DOI":"10.1152\/ajpendo.00134.2023","volume":"325","author":"AB Klein","year":"2023","unstructured":"Klein, A. B. et al. Cross-species comparison of pregnancy-induced GDF15. Am. J. Physiol. Endocrinol. Metab. 325, E303\u2013E309 (2023).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"1353_CR136","doi-asserted-by":"publisher","first-page":"bqae143","DOI":"10.1210\/endocr\/bqae143","volume":"165","author":"MC Mulcahy","year":"2024","unstructured":"Mulcahy, M. C. et al. GDF15 knockout does not substantially impact perinatal body weight or neonatal outcomes in mice. Endocrinology 165, bqae143 (2024).","journal-title":"Endocrinology"},{"key":"1353_CR137","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41572-019-0110-3","volume":"5","author":"MS Fejzo","year":"2019","unstructured":"Fejzo, M. S. et al. Nausea and vomiting of pregnancy and hyperemesis gravidarum. Nat. Rev. Dis. Prim. 5, 62 (2019).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"1353_CR138","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1016\/j.celrep.2018.01.044","volume":"22","author":"JE Jones","year":"2018","unstructured":"Jones, J. E. et al. Supraphysiologic administration of GDF11 induces cachexia in part by upregulating GDF15. Cell Rep. 22, 1522\u20131530 (2018).","journal-title":"Cell Rep."},{"key":"1353_CR139","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1038\/s41591-020-0945-x","volume":"26","author":"R Suriben","year":"2020","unstructured":"Suriben, R. et al. Antibody-mediated inhibition of GDF15-GFRAL activity reverses cancer cachexia in mice. Nat. Med. 26, 1264\u20131270 (2020).","journal-title":"Nat. Med."},{"key":"1353_CR140","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17670-y","volume":"11","author":"C Robert","year":"2020","unstructured":"Robert, C. A decade of immune-checkpoint inhibitors in cancer therapy. Nat. Commun. 11, 3801 (2020).","journal-title":"Nat. Commun."},{"key":"1353_CR141","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00432-022-04500-5","volume":"149","author":"G Hong","year":"2023","unstructured":"Hong, G. et al. Plasma GDF15 levels associated with circulating immune cells predict the efficacy of PD-1\/PD-L1 inhibitor treatment and prognosis in patients with advanced non-small cell lung cancer. J. Cancer Res. Clin. Oncol. 149, 159\u2013171 (2023).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"1353_CR142","unstructured":"Melero, I. et al. Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours. Nature 637, 1218\u20131227 (2024). Clinical trial showed anti-GDF15 antibody holds promise in overcoming resistance to anti-PD-1 and anti-PD-L1 treatments."},{"key":"1353_CR143","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.cmet.2023.01.002","volume":"35","author":"SN Breit","year":"2023","unstructured":"Breit, S. N., Brown, D. A. & Tsai, V. W. W. GDF15 analogs as obesity therapeutics. Cell Metab. 35, 227\u2013228 (2023).","journal-title":"Cell Metab."},{"key":"1353_CR144","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S0140-6736(18)31773-2","volume":"392","author":"PM O\u2019Neil","year":"2018","unstructured":"O\u2019Neil, P. M. et al. Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial. Lancet 392, 637\u2013649 (2018).","journal-title":"Lancet"},{"key":"1353_CR145","doi-asserted-by":"crossref","unstructured":"Aronne, L. J. et al. Tirzepatide as compared with semaglutide for the treatment of obesity. N. Engl. J. Med. 393, 26\u201336 (2025).","DOI":"10.1056\/NEJMoa2416394"},{"key":"1353_CR146","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1111\/dom.14663","volume":"24","author":"M Ghidewon","year":"2022","unstructured":"Ghidewon, M. et al. Growth differentiation factor 15 (GDF15) and semaglutide inhibit food intake and body weight through largely distinct, additive mechanisms. Diabetes Obes. Metab. 24, 1010\u20131020 (2022).","journal-title":"Diabetes Obes. Metab."},{"key":"1353_CR147","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.cmet.2023.01.001","volume":"35","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y. et al. Activity-balanced GLP-1\/GDF15 dual agonist reduces body weight and metabolic disorder in mice and non-human primates. Cell Metab. 35, 287\u2013298.e4 (2023).","journal-title":"Cell Metab."}],"container-title":["Nature Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42255-025-01353-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42255-025-01353-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42255-025-01353-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T11:03:09Z","timestamp":1787223789000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42255-025-01353-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,18]]},"references-count":147,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["1353"],"URL":"https:\/\/doi.org\/10.1038\/s42255-025-01353-3","relation":{},"ISSN":["2522-5812"],"issn-type":[{"value":"2522-5812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,18]]},"assertion":[{"value":"1 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the version of the article initially published, the editor recognition statement was missing and has now been added to the HTML and PDF versions of the article.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.N.B. is an inventor on patents owned by St Vincent\u2019s Hospital that cover the diagnostic and clinical applications of GDF15. V.W.T. declares no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}